Imbalance Between Th17 and Regulatory T-cells in Systemic Lupus Erythematosus
Overview
Affiliations
Impaired function of regulatory T-cells (Treg) leads to a failure in immune tolerance and triggers autoimmunity. We analyzed whether the deficiency in Treg in systemic lupus erythematosus (SLE) is accompanied by an increase in effector T-cell responses. We studied the frequencies of IL-17A (Th17) and IFNg (Th1) producing CD4(+) T-cells by flow cytometric detection of intracellular cytokines in PMA/ionomycin stimulated blood lymphocytes from seven patients with active SLE, eight with SLE in remission, and 11 healthy controls. Circulating Treg were evaluated as CD4(+)CD25(+) lymphocytes expressing FoxP3. There was no difference in the percentage of Treg cells between the groups, but their absolute counts were decreased in active SLE (5 [1-7] cells/μL) compared to inactive SLE (11 [6-15]; p = 0.05) and healthy controls (16 [10-20]; p 〈 0.01). Both the frequency and numbers of Th1 cells were decreased in SLE compared to controls. No difference was observed in the number of Th17 cells, which resulted in a decreased Th1/Th17 ratio. In parallel, a higher Treg/Th17 ratio in healthy controls (2.2 [1.8-3.6]) compared to active SLE (1.1 [1.0-2.1]; p 〈 0.05) was observed. There was a correlation between the number of Treg cells and disease activity status (SLEDAI, r = -0.59). SLE patients in the active phase of the disease are characterized by a deficiency in Treg cells and decreased Treg/Th17 ratio. This suggests that the imbalance between major T-cells subsets might be responsible for an increased proinflammatory response in the exacerbation of SLE.
Chen D, Sun F, Miao M, Wang Y, Jin Y, Zhang X Clin Rheumatol. 2025; 44(2):669-679.
PMID: 39760906 DOI: 10.1007/s10067-024-07254-2.
CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.
Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y Front Immunol. 2025; 15:1476859.
PMID: 39749335 PMC: 11694027. DOI: 10.3389/fimmu.2024.1476859.
Huang J, Li X, Zhu Q, Wang M, Xie Z, Zhao T Front Immunol. 2024; 15():1425847.
PMID: 39086480 PMC: 11288813. DOI: 10.3389/fimmu.2024.1425847.
Regulatory T Cell Dysfunction in Autoimmune Diseases.
Honing D, Luiten R, Matos T Int J Mol Sci. 2024; 25(13).
PMID: 39000278 PMC: 11241405. DOI: 10.3390/ijms25137171.
Nilsson M, Kozyrev S, Saellstrom S, Johansson S, Andersson G, Lindblad-Toh K Sci Rep. 2024; 14(1):11624.
PMID: 38773194 PMC: 11109178. DOI: 10.1038/s41598-024-62265-y.